Chemoinformaics analysis of Dihydrothiazine
Molecular Weight | 101.174 | nRot | 0 |
Heavy Atom Molecular Weight | 94.118 | nRig | 6 |
Exact Molecular Weight | 101.03 | nRing | 1 |
Solubility: LogS | 0.231 | nHRing | 1 |
Solubility: LogP | 1.485 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 13 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 15.3476 |
nHD | 1 | BPOL | 10.0524 |
QED | 0.459 |
Synth | 4.802 |
Natural Product Likeliness | 0.283 |
NR-PPAR-gamma | 0.487 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.015 |
HIA | 0.006 |
CACO-2 | -4.336 |
MDCK | 0.00000662 |
BBB | 0.973 |
PPB | 0.14185 |
VDSS | 1.384 |
FU | 0.847136 |
CYP1A2-inh | 0.694 |
CYP1A2-sub | 0.504 |
CYP2c19-inh | 0.168 |
CYP2c19-sub | 0.667 |
CYP2c9-inh | 0.023 |
CYP2c9-sub | 0.758 |
CYP2d6-inh | 0.134 |
CYP2d6-sub | 0.844 |
CYP3a4-inh | 0.032 |
CYP3a4-sub | 0.211 |
CL | 9.557 |
T12 | 0.741 |
hERG | 0.008 |
Ames | 0.734 |
ROA | 0.857 |
SkinSen | 0.938 |
Carcinogencity | 0.592 |
EI | 0.987 |
Respiratory | 0.742 |
NR-Aromatase | 0.604 |
Antiviral | No |
Prediction | 0.955861 |